- Nachrichtendetail
-
26.07.2024 14:47:13 - dpa-AFX: *CHMP RECOMMENDS J&J'S RYBREVANT WITH CHEMO FOR ADVANCED EGFR-MUTATED NSCLC
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Xetra | 147,560 | 20.09.24 12:16:45 | -0,140 | -0,09% | 147,440 | 147,860 | 147,800 | 147,700 |
